drugset / Trial / NCT01250197
Formulation Comparison in Normal Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
This is a double-masked, single-center, crossover study in which normal volunteers will be randomized to receive one of two formulations of 0.5% AR-12286 Ophthalmic Solution for 8 days. Subjects will undergo a minimum 7-day washout, and then receive the alternate treatment for 8 days.
Timeline
- Start
- 2010-11
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VEROSUDIL | Small molecule | 0.5 % | Other |
Indications
No indication recorded.